The possible mechanism behind the association of ERCC1 expression and chemotherapy resistance is as follows: Alkylating agents and platinum-based drugs basically cause tumor cell death by DNA damage and formation of DNA adducts, and one of the basic defense mechanisms against this DNA damage possessed by the cancer cells is DNA repair. Here, ERCC1 is linked to neoplasm.